Alzheimer's disease

News

Amid outcry over Aduhelm price, Biogen says it may consider ...

Biogen has hinted that it may consider altering the price of its controversially-approved Alzheimer's therapy Aduhelm – but only if its assumptions on population size and uptake are differe

News

Closeup of X-ray photography of human brain

BMS re-joins Alzheimer's push, paying $80m for Prothena's ta...

Just a few days after Biogen abandoned its tau-targeting Alzheimer's disease candidate gosuranemab, Bristol-Myers Squibb has opted into a rival drug, paying $80 million for rights to Prothe

News

Concept of memory loss and brain aging due to dementia and alzheimer's disease as a medical icon with fall trees shaped as a human head losing leaves with 3D illustration elements.

Biogen abandons tau antibody for Alzheimer's after phase 2 m...

Biogen has four other Alzheimer's candidates in its clinical pipeline behind recently-approved Aduhelm, but one of them – anti-tau antibody gosuranemab – has just been canned.

News

Consumer group seeks resignation of top FDA staffers over Ad...

With the first patient set to receive Biogen's new Alzheimer's drug Aduhelm in Rhode Island today, US consumer advocacy organisation Public Citizen is deeply unhappy about the FDA's approva

News

And then there were three: another FDA adcomm member quits o...

The fallout over the FDA's decision to approved Biogen's Alzheimer's therapy Aduhelm continues to be felt, with a third member of its advisory committee resigning in protest.

News

FDA slammed over Aduhelm OK as Biogen takes heat for $56k pr...

The FDA "has failed in its responsibility to protect patients and families from unproven treatments with known harms" in approving Biogen's Alzheimer's disease drug Aduhelm.

Amid outcry over Aduhelm price, Biogen says it may consider ...

BMS re-joins Alzheimer's push, paying $80m for Prothena's ta...

Biogen abandons tau antibody for Alzheimer's after phase 2 m...

Consumer group seeks resignation of top FDA staffers over Ad...

And then there were three: another FDA adcomm member quits o...

FDA slammed over Aduhelm OK as Biogen takes heat for $56k pr...

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Alzheimer's disease

Editor's Picks